Capital Region Pharmacy (Denmark)

Capital Region Pharmacy (Rigshospitalet) is the hospital pharmacy for the Capital Region of Denmark. RAP delivers drugs and hospital pharmacy services to 15 hospitals serving 2300 wards and other customers. The yearly turnover is 1.500 mio. DKK ( 200 mio. €) and the staff is app. 460 persons including
75 pharmacists, 230 pharmay technicians.
The hospital Pharmacy support 3 centres for cancer treatment and prepare app. 80.000 single doses of cytostatics per year for these centres.
The pharmacy has production departments and produces app. 2 mio. single containers of large volume parenterals, app. 300.000 patient oriented single doses of antibiotics, cytotoxics and TPN per year together with 1,4 mio. ampules and 13 mio. tablets.The pharmacy is approved and inspected by the Danish Medicines Agency according to the European GMP regulation.

Vagn Handlos

Senior Scientist Vagn Handlos, Director of Education, Science and Research, Congress. EAHP Capital Region Pharmacy Copenhagen Denmark

Born 14th August 1944 in Denmark,
Master of Sci. in pharmacy 1969,
Ph.D. in Pharmaceutical Technology 1974
Dr. of Pharmaceutical Sciences 1986.

1970-76 Ass. Professor and research fellow at the Royal Danish School of Pharmacy (RDSP) and the Danish Atomic Agency Laboratory, Risoe
1976 – 87 Senior Research Fellow at Risoe and RDSP
1987-2005 Director of the Copenhagen hospital pharmacy (Rigshospitalet).
2005 - Senior Scientist at RAP

Others
1983-96 Member of the European Pharmacopoeia working party on plastics for pharmaceutical use
1985 -88 Member of the Danish Technical Research Council
1990- Professor at Copenhagen University, Faculty of Pharmacy
1992- Member of the Danish Pharmacopoeia Commission
2005- Director of education, research and science, European Association of Hospital Pharmacists

As for other European Hospital Pharmacies the production volume of ready to use cytotoxic preparations is increasing year by year. For 2007 we now expect to reach a number of 80.000 single doses .By implementing  SafeChemo we do hope to solve the problems in increasing the number of staff and the hard work in the sterile areas. On the same time we have been tempted to join a pan European group for the evaluation of the automation of the process we run manually today!